FDA approves Roswell Park for clinical trial to fight COVID-19 in cancer patients


BUFFALO, N.Y. (WIVB) — The Food and Drug Administration (FDA) has authorized Roswell Park for a trial to fight coronavirus in cancer patients.

It’s one of the very few worldwide to repurpose experimental cancer therapy as treatment for COVID-19.

Patients with cancer and COVID-19 have a risk of severe illness up to five times higher than people without cancer, which makes coronavirus especially threatening.

Additional clinical sites for the study may eventually be added.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Now